Tag:
BioMimetic Therapeutics
Latest Headlines
Latest Headlines
FDA panel hands BioMimetic slim victory
BioMimetic Therapeutics ( $BMTI ) can claim a victory. An expert FDA advisory committee supported the safety and effectiveness of the Franklin, TN-based biotech's bone graft treatment for foot and
BioMimetic gets FDA panel nod by slim margin
An FDA advisory committee Thursday endorsed BioMimetic Therapeutics' ($BMTI) experimental drug-device combination product Augment, which is intended as an alternative to autograft procedures for
